Epperly Melissa B, 4
4 · Roivant Sciences Ltd. · Filed Sep 12, 2024
Insider Transaction Report
Form 4
Epperly Melissa B,
Director
Transactions
- Award
Common Shares
2024-09-10+16,406→ 40,669 total - Award
Stock Option (Right to Buy)
2024-09-10+27,894→ 27,894 totalExercise: $12.19Exp: 2034-09-09→ Common Shares (27,894 underlying)
Footnotes (2)
- [F1]Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date.
- [F2]Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 10, 2025, subject generally to the reporting person's continuous service through such date.